Creutzfeldt-Jakob Disease (CJD)
Overview of prion diseases.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Clinical Guidelines
NICE guideline [IPG666]: Reducing the risk of transmission of Creutzfeldt–Jakob disease
National
NICE Interventional Procedures Guidance [IPG666]: Reducing the risk of transmission of Creutzfeldt–Jakob diseaseNational
Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) and variant Creutzfeldt–Jakob disease (vCJD) via interventional procedures (NICE interventional procedures guidance [IPG666])National
CJD Diagnostic Criteria | Classic CJD | CDCLocal
Clinical Overview of Creutzfeldt-Jakob Disease (CJD)Local
Creutzfeldt-Jakob disease (CJD): guidance, data and analysisLocal
Guidelines for Environmental Infection Control in Health-Care FacilitiesLocal
NICE interventional procedures guidance [IPG666]: Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) and variant Creutzfeldt–Jakob disease (vCJD) by interventional proceduresLocal
Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood ComponentsLocal
Review of guidelines for prevention of Creutzfeldt–Jakob disease transmission in healthcare settingsLocal
Transmissible Spongiform Encephalopathies (including Creutzfeldt-Jakob Disease): WHO GuidanceLocal